Literature DB >> 26209647

Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells.

Cathelijne W van den Berg1, Satoshi Okawa2, Susana M Chuva de Sousa Lopes1, Liesbeth van Iperen1, Robert Passier1, Stefan R Braam3, Leon G Tertoolen1, Antonio del Sol2, Richard P Davis1, Christine L Mummery4.   

Abstract

Differentiated derivatives of human pluripotent stem cells (hPSCs) are often considered immature because they resemble foetal cells more than adult, with hPSC-derived cardiomyocytes (hPSC-CMs) being no exception. Many functional features of these cardiomyocytes, such as their cell morphology, electrophysiological characteristics, sarcomere organization and contraction force, are underdeveloped compared with adult cardiomyocytes. However, relatively little is known about how their gene expression profiles compare with the human foetal heart, in part because of the paucity of data on the human foetal heart at different stages of development. Here, we collected samples of matched ventricles and atria from human foetuses during the first and second trimester of development. This presented a rare opportunity to perform gene expression analysis on the individual chambers of the heart at various stages of development, allowing us to identify not only genes involved in the formation of the heart, but also specific genes upregulated in each of the four chambers and at different stages of development. The data showed that hPSC-CMs had a gene expression profile similar to first trimester foetal heart, but after culture in conditions shown previously to induce maturation, they cluster closer to the second trimester foetal heart samples. In summary, we demonstrate how the gene expression profiles of human foetal heart samples can be used for benchmarking hPSC-CMs and also contribute to determining their equivalent stage of development.
© 2015. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Gene expression profiling; Human heart development; Human pluripotent stem cells

Mesh:

Year:  2015        PMID: 26209647     DOI: 10.1242/dev.123810

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  72 in total

Review 1.  Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment.

Authors:  Shin Kadota; Yuji Shiba
Journal:  Curr Cardiol Rep       Date:  2019-06-21       Impact factor: 2.931

2.  Patient-derived induced pluripotent stem cells in cancer research and precision oncology.

Authors:  Eirini P Papapetrou
Journal:  Nat Med       Date:  2016-12-06       Impact factor: 53.440

Review 3.  Probing early heart development to instruct stem cell differentiation strategies.

Authors:  Damelys Calderon; Evan Bardot; Nicole Dubois
Journal:  Dev Dyn       Date:  2016-10-03       Impact factor: 3.780

Review 4.  Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine.

Authors:  Elaheh Karbassi; Aidan Fenix; Silvia Marchiano; Naoto Muraoka; Kenta Nakamura; Xiulan Yang; Charles E Murry
Journal:  Nat Rev Cardiol       Date:  2020-02-03       Impact factor: 32.419

5.  An Unbiased Proteomics Method to Assess the Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Wenxuan Cai; Jianhua Zhang; Willem J de Lange; Zachery R Gregorich; Hannah Karp; Emily T Farrell; Stanford D Mitchell; Trisha Tucholski; Ziqing Lin; Mitch Biermann; Sean J McIlwain; J Carter Ralphe; Timothy J Kamp; Ying Ge
Journal:  Circ Res       Date:  2019-10-01       Impact factor: 17.367

6.  Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.

Authors:  Lukas Cyganek; Malte Tiburcy; Karolina Sekeres; Kathleen Gerstenberg; Hanibal Bohnenberger; Christof Lenz; Sarah Henze; Michael Stauske; Gabriela Salinas; Wolfram-Hubertus Zimmermann; Gerd Hasenfuss; Kaomei Guan
Journal:  JCI Insight       Date:  2018-06-21

7.  Metabolic Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes by Inhibition of HIF1α and LDHA.

Authors:  Dongjian Hu; Annet Linders; Abir Yamak; Cláudia Correia; Jan David Kijlstra; Arman Garakani; Ling Xiao; David J Milan; Peter van der Meer; Margarida Serra; Paula M Alves; Ibrahim J Domian
Journal:  Circ Res       Date:  2018-10-12       Impact factor: 17.367

Review 8.  Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.

Authors:  Shi Hua Tan; Lei Ye
Journal:  J Cardiovasc Transl Res       Date:  2018-03-19       Impact factor: 4.132

9.  Reference glycan structure libraries of primary human cardiomyocytes and pluripotent stem cell-derived cardiomyocytes reveal cell-type and culture stage-specific glycan phenotypes.

Authors:  Christopher Ashwood; Matthew Waas; Ranjuna Weerasekera; Rebekah L Gundry
Journal:  J Mol Cell Cardiol       Date:  2020-01-21       Impact factor: 5.000

10.  Single-Cell Transcriptomic Analysis of Cardiac Differentiation from Human PSCs Reveals HOPX-Dependent Cardiomyocyte Maturation.

Authors:  Clayton E Friedman; Quan Nguyen; Samuel W Lukowski; Abbigail Helfer; Han Sheng Chiu; Jason Miklas; Shiri Levy; Shengbao Suo; Jing-Dong Jackie Han; Pierre Osteil; Guangdun Peng; Naihe Jing; Greg J Baillie; Anne Senabouth; Angelika N Christ; Timothy J Bruxner; Charles E Murry; Emily S Wong; Jun Ding; Yuliang Wang; James Hudson; Hannele Ruohola-Baker; Ziv Bar-Joseph; Patrick P L Tam; Joseph E Powell; Nathan J Palpant
Journal:  Cell Stem Cell       Date:  2018-10-04       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.